NEW YORK STATE COMMON RETIREMENT FUND - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q1 2022$372,000
+24.8%
5,934
+50.8%
0.00%
Q4 2021$298,000
-29.7%
3,934
+4.0%
0.00%
Q3 2021$424,000
-30.8%
3,7840.0%0.00%
-100.0%
Q2 2021$613,000
+4.1%
3,784
-21.7%
0.00%0.0%
Q1 2021$589,000
-51.0%
4,834
-38.4%
0.00%0.0%
Q4 2020$1,201,000
+445.9%
7,844
+197.8%
0.00%
Q3 2020$220,000
+13.4%
2,6340.0%0.00%
Q2 2020$194,000
+73.2%
2,6340.0%0.00%
Q1 2020$112,000
-67.4%
2,634
-53.3%
0.00%
Q4 2019$344,000
+224.5%
5,645
+118.5%
0.00%
Q3 2019$106,000
+5.0%
2,584
+21.1%
0.00%
Q2 2019$101,000
+21.7%
2,134
-8.6%
0.00%
Q1 2019$83,000
+16.9%
2,334
-6.0%
0.00%
Q4 2018$71,000
-77.5%
2,484
-65.0%
0.00%
Q3 2018$315,000
-44.1%
7,103
-25.9%
0.00%
-100.0%
Q2 2018$564,000
+27.3%
9,591
-1.0%
0.00%0.0%
Q1 2018$443,000
+119.3%
9,691
+12.9%
0.00%
Q4 2017$202,000
-41.3%
8,584
-55.5%
0.00%
Q3 2017$344,00019,2760.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2022
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
View complete list of CRISPR THERAPEUTICS AG shareholders